Odyssean »

Royal Gold shares owned by Odyssean

Quarter-by-quarter ownership of Royal Gold (RGLD) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Royal Gold

Tip: Access up to 7 years of quarterly data

All positions including Royal Gold held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royal Gold by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $518k 2.6k 199.61

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Royal Gold

Capital World Investors
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Van Eck Associates Corp.
Invesco
Geode Capital Management
Capital Research and Management Company - Division 3
Morgan Stanley
Northern Trust
First Eagle Investment Management
FMR
Capital Research Global Investors
Dimensional Fund Advisors

View all funds holding Royal Gold